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Abstract
The complete surgical removal of disease is a desirable outcome particularly in oncology. Unfortunately much
disease is microscopic and difficult to detect causing a liability to recurrence and worsened overall prognosis with
attendant costs in terms of morbidity and mortality. It is hoped that by advances in optical diagnostic technology
we could better define our surgical margin and so increase the rate of truly negative margins on the one hand
and on the other hand to take out only the necessary amount of tissue and leave more unaffected non-diseased
areas so preserving function of vital structures. The task has not been easy but progress is being made as
exemplified by the presentations at the 2nd Scientific Meeting of the Head and Neck Optical Diagnostics Society
(HNODS) in San Francisco in January 2010. We review the salient advances in the field and propose further
directions of investigation.
Introduction
Optical technologies are being used not only to detect
disease but also direct treatment (laser) and activate
photodynamic therapy as well as in cases aid in the acti-
vation of nano-devices to deliver a therapeutic effect.
We briefly outline some of the excellent evidence pre-
sented in the 2nd Scientific Meeting of the Head and
Neck Optical Diagnostics Society (HNODS), (Figure 1)
in San Francisco in January 2010.
I. Diagnostic
Disease detection
Optical diagnostics have proved to be a reliable resource
that can be used to provide an instant diagnosis of soft
and, more recently, hard tissue diseases. In the field of
head and neck malignancy, most of the experimental
spectroscopy work has been performed using fluores-
cence spectroscopy, Raman spectroscopy, elastic
scattering spectroscopy, micro-endoscopy and optical
coherence tomography. These have all shown a marked
increase in the sensitivity and specificity when com-
pared to both clinical examination and frozen section
analysis [1].
Optical biopsies can be acquired through different
modalities; each has it own mechanism of action and
requires different modes of data analysis. However, they
share the ability of being able to provide a real time,
non-invasive and in situ optical signature. Most of these
techniques have been applied only in clinical trials and
are yet to be employed in clinical practice, with the
exception of fluorescence spectroscopy. Results from
these trials are very promising and current results indi-
cate the possibility of these techniques being applied in
clinical practice in the next few years. This could have a
great impact on diagnostics, by reducing the histo-
pathology workload, reducing patient’s anxiety, and
allowing rapid surgical or adjuvant intervention [1].
Further miniaturization has reduced the size of micro-
endoscopic multi-photon imaging devices allowing
further clinical applications to be developed [2].
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Applications of optical technologies for diagnosis of lung
pathology
Visualizing the respiratory mucosa in pulmonary airways
at the sub-cellular level could yield new insights into
pathogenesis of many important diseases. However, cur-
rent imaging modalities to study the respiratory mucosa
lack the required resolution to visualize critical sub-cellu-
lar detail such as nuclei and respiratory epithelial cilia [3].
Full-field optical coherence microscopy (FFOCM) is an
emerging technique capable of providing reflectance
images in situ with high spatial resolution in all three
dimensions. Liu et al. have developed a FFOCM with an
axial sectioning thickness of 1 μm and a high transverse
resolution of 0.6 μm. Individual epithelial cells and goblet
cells, including their sub-cellular morphologies, were seen.
Their results demonstrated the potential of FFOCM to
provide detailed micro-structural imaging of pulmonary
airways without administration of a contrast medium [3].
Investigating the structure and function of pulmon-
ary alveoli in vivo is crucial for understanding the
normal and diseased lung. In particular, understanding
the three-dimensional geometry and relationship of the
terminal alveoli to their neighboring alveoli, alveolar
ducts and acini during respiration would be a major
advance. However, the lung is an inherently difficult
organ to image in vivo and the peripheral lung has
many compounding challenges not limited to its highly
scattering micro architecture, large motion artifacts
and difficult access through the bronchial tree. Namati
et al. used a high-speed high-resolution optical fre-
quency domain imaging (OFDI) system that is endos-
copically compatible for future in vivo imaging of
human alveoli. They showed that OFDI images reveal
clear delineation of alveolar septal walls, demonstrating
that high-speed three-dimensional visualization of air
filled alveoli is feasible [4].
Lung disease involving the alveoli and distal bronch-
ioles are poorly understood and most commonly studied
indirectly via lung function tests. Unglert et al. showed
that alveolar microstructure could be resolved in three
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dimensions in images obtained by intra-vital fluorescence
microscopy and optical coherence tomography [5].
Furthermore, lung cancer is the leading cause of
cancer-related death, and despite recent efforts to
reduce the mortality associated with the disease, patient
prognosis remains poor with the current 5-year survival
rate under 15%. Detection and diagnosis of lesions aris-
ing in the bronchial mucosa remains problematic and as
a result they are typically well advanced upon discovery.
Suter et al. described their experience in using optical
frequency domain imaging (OFDI) to interrogate the
bronchial mucosa of patients with the suspicion of lung
cancer. During bronchoscopic evaluation, regions of
interest suspicious of cancer or precursor lesions were
identified and imaged, in addition to regions of normal
appearing mucosa. OFDI imaging of the pulmonary air-
ways may enable the early detection of airway features
associated with the development of cancer. When used
as a screening tool in high-risk patients, it is hoped that
early detection of airway-associated cancer with OFDI
will result in a decrease in patients’ mortality [6].
Applications of optical technologies for diagnosis of oral
and head and neck pathology
Non-invasive differentiation of pre- and early malignant
mucosal changes may be helpful to reduce the morbidity
and shorten the time to diagnosis for the patients con-
cerned. Optical Coherence Tomography (OCT) seems
to be well suited to reach this goal. Volgger et al.
reviewed 82 primary leukoplakic or erythroplakic muco-
sal lesions of the upper aero-digestive tract (UADT)
prospectively using an in vivo, time-domain OCT. They
found that down to a depth of 1.5 mm, micro-anatomi-
cal structures were clearly identifiable on the OCT
images. OCT reached a sensitivity of 100% and a specifi-
city of 92% or 75% (investigator unblinded or blinded to
visual inspection), respectively. This method seems
highly promising for early, non-invasive tumour diagno-
sis in the UADT [7].
Optical biopsy systems have been investigated for var-
ious clinical applications; however the main interest
remains in the diagnosis and monitoring of premalig-
nant and malignant conditions. Hamdoon et al. acquired
suspicious oral lesions from 120 patients which were
then subjected to immediate ex vivo Swept-Source
Frequency-Domain OCT. They suggested that the use
of OCT in clinical examination and monitoring can be
invaluable tool for inexperienced clinicians [8]. Optical
coherence tomography (OCT) is a promising method in
the early diagnosis of oral cavity cancer. Prestin et al.
showed that depending on the location within the oral
cavity, the epithelium demonstrated a varying thickness.
The highest values were found in the region of the ton-
gue and the cheek, whereas the floor of the mouth
showed the thinnest epithelium [9].
Rubinstein et al. found that the OCT system is non-
invasive and easy to incorporate into the operating
room as well as to the outpatient clinic. It requires
minimal set-up and requires only one person to operate
the system. OCT has the distinctive capability to obtain
high-resolution images, where the microanatomy of dif-
ferent sites can be observed. OCT technology has the
potential to offer a quick, efficient and reliable imaging
method to help the surgeon not only in the operating
room but also in the clinical setting to guide surgical
biopsies and aid in the decision making of different
head and neck pathologies [10].
For oral cancer, biopsy has a low specificity because of
a thick keratin layer that often covers potential malig-
nancies. Sterenborg et al. investigated the possibility to
distinguishing potentially malignant visible lesions from
benign ones using differential pathlength spectroscopy
(DPS) to reduce the number of unnecessary biopsies in
75 suspicious lesions and 35 clinically normal locations
that were not biopsied. They showed that the area
under the ROC curve was 0.951 [11]. Pierce et al. devel-
oped a portable system to enable high-resolution evalua-
tion of cellular features within the oral mucosa in situ.
This system is essentially a wide-field epi-fluorescence
microscope coupled to a 1 mm in diameter flexible
fiber-optic imaging bundle capable of imaging nuclear
size and nuclear-to-cytoplasmic ratio following topical
application of a fluorescent labeling solution [12].
The development of lymphadenopathy in the neck has
many causes, in children it is often found in relation to
infection and in a small but significant number it is the
first presentation of lymphoma. In adults neoplastic
causes predominate for example, lymphoma, squamous
cell carcinoma and adenocarcinoma. The treatment
modalities and prognosis for these conditions varies
enormously and in the case of squamous cell carcinoma,
an excision biopsy can lead to significant morbidity. Orr
et al. investigated the ability of Raman spectroscopy to
differentiate between the major neoplastic diseases of
lymph nodes presenting within the neck. Pre-treatment
accurate diagnosis is imperative and is a compelling
argument for investment in the development of accu-
rate, sensitive and minimally invasive diagnostic techni-
ques, such as Raman spectroscopy [13].
Thyroid cancer is the most common endocrine malig-
nancy. The standard of care in the management of a
patient with a thyroid nodule is fine-needle aspiration
(FNA) biopsy with cytological evaluation. While 5-10%
of nodules are malignant, 10-25% of FNAs’ are indeter-
minate. Consequently, about twice as many patients
undergo surgery for a suspicious lesion that turns out to
be benign to patients undergo surgery for a known
malignant lesion. A more accurate molecular and ultra-
structural based algorithm would be useful to improve
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diagnostic accuracy. Non-invasive optical tissue diagno-
sis mediated by fiber-optic probes can be used to per-
form non-invasive, or minimally-invasive, real-time
assessment of tissue pathology in situ. Elastic light-
scattering spectroscopy (ESS) is a point spectroscopic
measurement technique, which is sensitive to cellular
and sub-cellular morphological features. Normal and
abnormal tissues can generate different spectral signa-
tures as a result of changes in nuclear size, density, and
other sub-cellular features, the optical-spectroscopy
equivalent of histopathological readings. ESS is optimal
for use in the small-volume area as found in thyroid
FNA. An important advantage of ESS is that it provides
an objective and quantitative assessment of tissue
pathology that may not require on-site special expertise
and subjective image interpretation as in conventional
histopathology. Rosen et al. described their experience
in the clinical application of elastic scattering spectro-
scopy in the thyroid [14].
Within the discipline of Otology, Just et al. used OCT
images and 3D reconstructions demonstrate the useful-
ness of OCT to measure the drilling cavity, to visualize
the inner ear structures, and to obtain micro-anatomical
information about the round and oval window niche.
They suggested that OCT-guided drilling allows identifi-
cation of the intact inner ear more precisely [15]. Opti-
cal coherence tomography is a unique technique to
visualize subsurface tissue structures with a resolution
below 10 μm during microsurgery without tissue con-
tact. A non-contact volumetric imaging with less than
15 μm resolution can guide microsurgery in Otolaryn-
gology (i.e. middle ear or tumor surgery of the vocal
fold) and in other medical disciplines [16].
Visible light is a source of energy known to activate
the visual system through absorption by photoreceptors
in the eye. When the “stress-confinement” condition is
fulfilled, laser light can induce an acoustic signal
through an opto-acoustic effect. Wenzel et al. sought to
assess if visible light with parameters that induce an
optoacoustic effect (i.e., 532 nm, 10 ns pulses) could be
used to stimulate the peripheral hearing organ at ear
drum and middle ear level. The group demonstrated
that visible light can be used to activate the peripheral
hearing organ when applied at the ear drum level or on
bony structures within the middle ear that can transmit
vibrations to the cochlea or inner ear. They suggested
that the technique could be used to improve implanta-
ble and non-implantable hearing [17].
Wisweh et al. showed that automated classification of
laryngeal lesions using optical coherence tomography
data can be helpful in making a faster and safer diagno-
sis. A change in the epithelial layer thickness seems to
be an effective indicator for laryngeal cancer and its
precursors [18].
Within the discipline of dentistry, Choo-Smith et al.
are developing a combined optical coherence tomogra-
phy (OCT) and polarized Raman spectroscopy (PRS)
system for the detection of early non-cavitated dental
caries. OCT provides high resolution morphological
depth imaging of incipient caries. In combination, OCT
and PRS have potential for detecting and monitoring
early lesions with high sensitivity and high specificity
[19].
Guidance of therapies
Optical technologies improve a clinician’s ability to dis-
criminate between normal and diseased tissue. This has
obvious advantages including automation, objectivity
and reproducibility to give consistent results with
defined accuracies.
In the treatment of cancer, the fundamental surgical
goal is to remove all local malignant disease and leave
no residual malignant cells. Studies have demonstrated
the benefit of achieving negative resection margins in
terms of disease free local recurrence and overall survi-
val. The surgical margins for head & neck cancer may
vary widely depending on the site of disease. Assessment
of tumour resection margins using optical coherence
tomography was performed by Hamdoon et al. in 25
patients with early stage oral squamous cell carcinoma
(OSCC) who underwent local resection. The group
found that the junctional epithelium (between positive
and negative margins) can be identified by gradual
change in epithelial thickness and basement membrane
organisation (integrity) from the normal to pathological.
They also identified changes in tumour positive margins
including hyper-keratinisation, breach of the basement
membrane and dis-organised epithelial structure. More-
over, the tumour spread pattern could be identified on
the majority of the interrogated tissue [20].
Tissue remodeling
The use of optical technologies to reshape tissue struc-
tures is important in reconstructive and cosmetic sur-
gery. Electromechanical reshaping (EMR) of cartilage is
a promising non-invasive technique with potential for
broad application in reconstructive surgery. EMR
involves applying direct current electrical fields to loca-
lized stress regions and then initiating a series of oxida-
tion-reduction reactions, thus effecting a shape change.
Previous EMR studies have focused on macroscopic
structural measurements of the shape change effect or
monitoring of electrical current flow. OCT provides a
means to gauge structural changes in the tissue matrix
during EMR. Chen et al. described the application of
OCT to image the EMR process to improve our under-
standing of the mechanisms of action involved and
potentially facilitate optimization of this process [21].
Furthermore, in 1992, laser-induced stress relaxation
in cartilage was identified. This led to the development
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of non-ablative laser reshaping of cartilage. Laser septo-
chondral correction is non-invasive, bloodless, painless
procedure which takes only 10 minutes to complete and
can be performed in outpatient settings. The efficacy
and safety of this technology can be improved with the
feed back control system measuring temperature and
stress distribution in the course of laser treatment.
Sobol et al. presented recent results of the research and
clinical applications of the technology and equipment
for laser reshaping of cartilage in the ENT in 120
patients. The positive results were obtained for 95 per-
cent of the patients in two years follow-up [22].
Grafts obtained from peripheral regions of costal carti-
lage have an inherent tendency to warp over time. Laser
irradiation provides a potential method to control the
warping process, thus yielding stable grafts for facial
reconstructive surgery. Foulad et al. proposed a model
for assessing the effect of laser irradiation on the warping
process of costal cartilage using optical technology [23].
II. Therapeutic
The therapeutic use of optical techniques ranges from
the direct use of optical wavelengths for delivering treat-
ment to the use of light to specifically activate photo-
chemicals to affect tumour lysis with minimal bystander
tissue effects. Since many of these technologies are sur-
gically or microscopically directed, the accuracy and
resolution of the treatment volume far exceeds that
obtained by radiotherapy.
Stepp & Betz showed the feasibility of semi-
quantitative endoscopic guided perfusion measurements
using ICG-angiographies in 25 patients with free-tissue
transfer to the upper aero-digestive tract. The method
was shown to be easy to perform with no adverse
events. A method for simultaneous ICG-fluorescence
and white light imaging was presented. The team sug-
gested that the methodology was suited to situations
with questionable flap vasculature Doppler signals, or
when flaps are otherwise difficult to monitor [24,25].
Direct use of optical technology
Lasers have been used by a number of researchers to
close wounds in controlled laboratory tests over the last
15 years. Larson et al. presented their experience using
a device to fuse tissue membranes as an alternative to
sutures or staples for the coaptation of mucoperichon-
drial membranes. Coaptation is accomplished through
the controlled application of laser heating to induce pro-
tein denaturation and subsequent renaturation across
the interface. They identified the important parameters
involved in fusing biological tissues using radiation from
laser sources following computational modeling of the
fusion process based on engineering first-principles
from heat transfer, fluid dynamics and optics, and from
experimental results on a particular tissue system [26].
An interesting application was presented by Fishman
et al. Advancements in implantable auditory prostheses
now demand preservation of residual auditory function
following the surgery. Atraumatic cochleostomy formation
is essential to this goal. Clinically reported hearing out-
comes in human implantation are still quite variable in
this regard. It was suggested that CO2 laser operated with
a handheld hollow waveguide can consistently produce
cochleostomies without damaging the residual auditory
function. Fishman et al. demonstrated that for a careful
selection of the laser’s power, the safety range for the laser
is superior to the safety range of drilling. Particularly
important is the finding that multiple laser pulses through
the same cochleostomy do not further increase the initial
compound action potential (CAP) threshold elevation.
Moreover, multiple laser pulses at different locations of
the cochlea do not further increase the initial CAP thresh-
old elevation observed after the first laser pulse [27].
Eustachian tube dysfunction is very common and is
the predominant cause of otitis media with effusion.
Negative middle ear pressure generated by Eustachian
tube dysfunction can cause deformation of the collagen
layer in the ear drum. Kaylie and Miller presented their
findings after laser myringoplasty using the Omniguide
hand-held flexible fiber CO2 laser in 22 patients which
showed immediate hearing improvement and eardrum
contraction [28].
CO2 trans-oral laser microsurgery (TLM) is an emer-
ging technique for the management of laryngeal cancer
and other head and neck malignancies. This technique
has become more widely used by head and neck sur-
geons progressively replacing traditional open surgical
procedures because it is better at preserving organ func-
tion with lower overall morbidity. The CO2 laser is
coupled to a micromanipulator and microscope, which
provides enhanced tumor visualization and the ability to
perform precise tissue cuts, obtain excellent haemosta-
sis, and avoid damaging the surrounding tissues and
structures that are transected during open surgical pro-
cedures. Armstrong et al. reflected upon their decade of
experience in TLM, they felt that the improved instru-
mentation, demonstration of oncologic effectiveness,
clinical experience using TLM and decreased morbidity
has led to an increased utilization of TLM by head and
neck surgeons. Successful surgery requires adequate
visualization, precise cutting, controlled depth of tissue
penetration, and ability to obtain tissue haemostasis.
The full spectrum of laser power settings, spot sizes and
energy pulse delivery modes is utilized to resect mucosa,
fat, muscle, connective tissue and cartilage while avoid-
ing inadvertent damage to nerves and large vessels, and
obtaining adequate haemostasis [29].
The use of CO2 laser in the management of oral dys-
plastic lesions has been put into practice for more than
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a few years now. The main advantage is the decrease in
local tissue morbidity. Very few studies have evaluated
recurrence, malignant transformation and overall out-
come in patients undergoing such procedure. Jerjes
et al. applied CO2 laser in a prospective study of 123
oral dysplastic lesions followed-up for 6.4 years. Recur-
rence and/or malignant transformation of oral dysplasia
were observed following laser surgery. They recom-
mended laser resection/ablation for oral dysplasia to
prevent not only recurrence and malignant transforma-
tion, but also postoperative oral dysfunction encoun-
tered by other conventional modalities. The use of
trans-oral robotic flexible CO2 laser with fluorescence
and narrow band imaging control was commended [30].
The incidence of oral squamous cell carcinoma
(OSCC) remains high. Oral carcinomas are the sixth
most common cancer in the world. Squamous cell carci-
noma of the oral cavity has a poor overall prognosis
with a high tendency to recur at the primary site and
extend to involve the cervical lymph nodes. Jerjes et al.
followed-up 73 patients for 3 years in prospective study
to evaluate the oncological outcomes following trans-
oral CO2 laser resection of T1/T2 N0 OSCC. Tumour
clearance was primarily achieved in 73 patients. Follow-
up resulted in a 3-year survival of 87.8%. Recurrence
was identified in 12% of the patients. The mean age of
1st diagnosis of the recurrence group was 76.4 years.
Most common oral sites included the lateral border of
tongue and floor of mouth. Recurrence was associated
with clinical N-stage disease. The surgical margins in
this group were also evaluated [31].
Vocal fold scarring can arise from disease or post-
surgical wound healing and is one of the predominant
causes of voice disorders. Focused ultrafast laser pulses
have been demonstrated to create tightly confined sub-
surface ablation in a variety of tissue, including vocal
folds. Ben-Yakar et al. demonstrated how the unique
ability of ultrafast laser ablation to create sub-surface
vocal fold microsurgeries could be used for eventually
creating a plane in tough sub-epithelial scar tissue into
which biomaterials can be injected. They found that the
use of relatively high repetition rates, with a small num-
ber of overlapping pulses, is critical to achieving ablation
in reasonable amounts of time while still avoiding signif-
icant heat deposition. Additionally, they used multi-
photon fluorescence of the ablation region and SHG
imaging of collagen fibers to obtain visual feedback of
tissue structure and confirm successful ablation [32].
Photodynamic therapy
Analogous to 3D dosimetry planning for radiotherapy
attempts are being made to plan interstitial photody-
namic therapy (iPDT), using multiple linear light
sources positioned within the tumour. In an on-going
feasibility study in the Netherlands, 16 patients with
incurable SCC at the base tongue have been treated
with iPDT as a last treatment option. Preliminary results
are encouraging with a long-term complete response in
8 out of 16 patients who have failed standard treatment.
There is strong evidence that the partial responders are
a direct result of inadequate light delivery [33].
Accurate light dosimetry has not yet been performed
during iPDT in the head and neck. van Veen et al.
proposed the development of dedicated iPDT verifica-
tion and planning technology to improve the clinical
response and reduce the occurrence of side effects.
Their results so far indicate good conservation of func-
tions i.e. swallowing, and excellent local control of the
tumour. Interstitial PDT may offer an excellent alter-
native or adjuvant for conventional treatment modal-
ities [33].
Photodynamic therapy with m-THPC is an established
treatment for superficial squamous cell carcinoma and
is also being considered for treatment of larger head
and neck tumors. Recently, clinical implementation of
m-THPC-mediated PDT in the head and neck has not
been optimal; a subset of patients has experienced
incomplete response. It is well-understood that sufficient
quantities of light, drug and oxygen must be present in
the targeted tissue in order to deliver sufficient damage.
This requirement is complicated by variations in the tis-
sue optical properties and in the photo-sensitizer uptake
rates; however, most clinical protocols do not measure
the effect of these factors on the PDT dose delivered to
individual patients [34,35].
Kanick and de Visscher et al. described the use of
optical techniques developed to monitor PDT treat-
ments in pre-clinical models into the clinical treatment
of head and neck cancer. Their techniques incorporated
reflectance and fluorescence spectroscopic measure-
ments into the PDT-treatment protocol. They found
that spectral analysis allowed the extraction of m-THPC
concentrations and the quantitative determination of tis-
sue physiological parameters that are important to the
PDT-delivered dose (i.e. blood volume and hemoglobin
saturation). They described the practical and technical
challenges of translating these techniques into the clini-
cal setting [34,35].
Photodynamic therapy, the fourth oncological inter-
ventional modality has proved its successfulness in the
management of variety of pathologies involving the
human body. University College London (UCL)
researchers evaluated the outcome following ultrasound-
guided iPDT of pathologies involving the head and neck
region as well as the upper and lower limbs in 110
patients. Clinical assessment showed that more than half
of the patients had “good response” to the treatment
and a third reported “moderate response”. Radiological
assessment comparing imaging 6-week post-PDT to the
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baseline showed moderate response in half of the
patients and significant response in 20% of patients [36].
Optical technologies can be used to activate therapy in
a particular location directed by imaging modalities to
improve co-location of therapy to disease states. Photo-
dynamic therapy (PDT) is a minimally invasive surgical
intervention used in the management of tissue disorders.
It can be applied before, or after, any of the conven-
tional modalities, without compromising these treat-
ments or being compromised itself. PDT is valuable for
potentially malignant disorders. Hopper et al. on a study
of 147 patients showed that 5-ALA-PDT and/or
mTHPC-PDT offer an effective alternative treatment for
potentially malignant oral disorders. It is associated with
excellent functional and cosmetic results and can be
used in conjunction with other standard therapies [37].
Shafirstein et al. further showed the safety and efficacy
of photodynamic therapy (PDT) in the treatment of oral
leukoplakia with 5-aminolevulinic acid (5-ALA) and
pulsed dye laser (PDL) confirmed with fluorescence
diagnosis system. They determined that high power
laser activation allowed completing the laser therapy
within 1-3 minutes with a significant response in up to
46% [38].
Professor Biel presented an excellent account of the
clinical application of photodynamic therapy for ENT
cancers. Carcinoma of the larynx accounts for 25-30%
of all carcinomas of the head and neck. Early carcino-
mas of the larynx (Tis or T1) and severe dysplasia are
presently treated with either radiation therapy or surgery
alone. Photodynamic therapy has been demonstrated to
be effective in the treatment of early carcinomas of the
larynx, Tis and T1, with cure rates of 90% with follow-
up to 236 months. The advantage of PDT for early car-
cinomas of the larynx is the ability to preserve normal
endo-laryngeal tissue while effectively treating the carci-
nomas. This results in improved laryngeal function and
voice quality. Furthermore, PDT requires a short dura-
tion of therapy as compared to radiation therapy. PDT
is repeatable and carries less risk than surgical therapy
and is performed as an outpatient non-invasive treat-
ment. Importantly, the use of PDT does not preclude
the use of radiotherapy or surgery in the future for new
primary or recurrent disease [39].
Within oro-pharyngeal oncology the management of
base of tongue carcinoma continues to be a major chal-
lenge in head and neck oncology especially after chemo-
radiation failure and the poor reconstructive prospects
of total glossectomy with laryngectomy as the remaining
salvage option. Without advances in pathological confir-
mation of previously irradiated fibrotic tongue base tis-
sue the efficacy of robotic trans-oral laser resection is
still unproven but very promising. Jerjes et al. evaluated
the outcome following ultrasound-guided interstitial
photodynamic therapy (US-iPDT) of stage IV tongue
base carcinoma in 33 patients followed-up for
18 months. Their clinical assessment showed that two-
thirds of the patients had “good response” to the treat-
ment and a third reported “moderate response” [40].
Advances in diagnosis and therapy
Jerjes et al. also described their experiences with a phase
I dose escalating study of photochemical internalization
(PCI), which is a novel technology that facilitates the
delivery of oncotoxic macromolecules into cytoplasm.
The initial mechanism and practical application was
described by Berg et al. in 1999. The group evaluated
the safety and tolerance of the photo-sensitizer (amphi-
nex) that is used to initiate the photochemical internali-
zation process with bleomycin as the chemotherapeutic
agent. The most striking finding was the dramatic
tumour responses. The starting dose of Amphinex for
the study was set at a level not expected to trigger a
PCI response, however there appeared to be a localized
synergistic effect with photo-activation [41].
It is now known that the presence of biofilms in the
upper aero-digestive tract prevents the adequate treat-
ment of infections because the infecting agents remain
sequestered in an environment away from circulating or
topical agents such as antibiotics. The treatment of
these recidivist infections is difficult although the use of
selected detergents has shown promise. An alternative
treatment option is the use of PDT which was shown to
be effective in vivo by Rhee et al. using H. Influenza bio-
films with over 66% resolution of otitis media, one of
the most common childhood diseases [42].
Naturally the next step in the utilization of optical
technologies is in the shaping and control of nano
devices. An innovative use of optical technology in the
activation of nano-devices to promote chondrocyte
growth across Ti:Sapphire Femto second laser micro-
structured titanium prosthesis coated with bioactive
proteins was shown by Ilgner et al. to improve bio-
integration and sound transmission [43].
In summary, we briefly outlined some of the excellent
evidence presented in the 2nd Scientific Meeting of the
Head and Neck Optical Diagnostics Society (HNODS)
in San Francisco initially relating to disease diagnostics,
including detection and guidance for biopsies and treat-
ment and then focusing upon the therapeutic use of
optical technologies either directly or by activating
treatments.
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